Obesity: Drugs
Commons · Question 73129 · Tabled 29 Aug 2025 · Department of Health and Social Care · Official record
Answered 10 Sep 2025
Question
Asked by Andrew Snowden
To ask the Secretary of State for Health and Social Care, how the Medicines and Healthcare products Regulatory Agency plans to improve the (a) monitoring and (b) reporting of adverse effects related to weight loss drugs; and what systems are in place to e
Answer
Answered by Karin Smyth, 10 Sep 2025
The Yellow Card scheme collects reports of suspected adverse effects for all healthcare products including weight loss drugs. Reporting is open to all healthcare professionals and members of the public through a variety of methods including online, via th...